Skip to main content

Severe Hypertriglyceridemia

Hightower’s past efforts aim to manage and treat this condition effectively and have better patient outcome.

                       

About Severe Hypertriglyceridemia Study

Severe hypertriglyceridemia is a condition characterized by high levels, typically at or above 500 mg/dL. This condition is concerning because it can significantly increase the risk of developing acute pancreatitis, an inflammation of the pancreas.

Hightower Clinical conducted a study to assess the effectiveness of a new drug treatment in managing triglyceride levels in individuals with severe hypertriglyceridemia. The goal was to evaluate the drug’s ability to reduce the risk of complications associated with this condition.

Current Status

Not Recruiting

Study Count

3

Study Information

Organized Severe Hypertriglyceridemia Clinical Trials

Study NameProtocol NumberSponsor
Severe HypertriglyceridemiaISIS 678354-CS5Ionis Pharmaceuticals, Inc.
ISIS 678354-CS15Ionis Pharmaceuticals, Inc.
ISIS 678354-CS9Ionis Pharmaceuticals, Inc.

Frequently Asked Questions

What are the symptoms of severe hypertriglyceridemia?

Often there are no symptoms, but some people may experience abdominal pain, nausea, or fatigue.

What are the risks of severe hypertriglyceridemia?

The main risk is pancreatitis, a dangerous inflammation of your pancreas. It can also increase your risk of heart disease.

Why would I participate in a clinical trial for severe hypertriglyceridemia?

Clinical trials test new treatments that could help lower your triglycerides more effectively or with fewer side effects than current medications.

Am I eligible for a clinical trial for severe hypertriglyceridemia?

Eligibility criteria vary, but trials often look for people with triglyceride levels above a certain threshold. Talk to your doctor to see if a trial might be right for you.